Cullinan Therapeutics (NASDAQ:CGEM – Get Free Report) had its price objective boosted by investment analysts at HC Wainwright from $28.00 to $33.00 in a research note issued to investors on Wednesday, ...

Equities researchers at HC Wainwright increased their Q2 2025 earnings per share (EPS) estimates for shares of Atara ...

Fintel reports that on January 30, 2025, HC Wainwright & Co. initiated coverage of Knightscope (NasdaqCM:KSCP) with a Buy ...

In a report released today, Kevin Dede from H.C. Wainwright maintained a Buy rating on Neptune Digital Assets (NDA – Research Report), with a ...

H.C. Wainwright lowered the firm’s price target on McEwen Mining (MUX) to $18 from $19 and keeps a Buy rating on the shares following the 2024 ...

Fintel reports that on January 30, 2025, HC Wainwright & Co. downgraded their outlook for CARGO Therapeutics (NasdaqGS:CRGX) from Buy to Neutral. Analyst Price Forecast Suggests 146.36% Upside As of ...

Notable insider trades include Morrison Alex G, Director at Energy Fuels Inc (UUUU), who sold 17500 shares on Dec 18 ’24, at $5.72 each, totaling $0.10 million. On Nov 19 ’24, HIGGS DENNIS LYLE, ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 28.87% ...

On Wednesday, H.C. Wainwright reaffirmed a Buy rating on shares of TG Therapeutics (NASDAQ:TGTX) shares with a steady price target of $55.00. The firm's analyst highlighted the company's strong ...

On Tuesday, H.C. Wainwright maintained a Buy rating on Akebia Therapeutics (NASDAQ:AKBA) stock with a steady price target of $7.50, significantly above the current trading price of $1.88. The firm's ...